1Grove AL, Meredith JO, Macintyre M, et al. Lean imple- mentation in primary care health visiting services in Na- tional Health Service UK[J].Qual Saf Health Care, 2010,19(5) : e43.
2Ogata A, Morita T, Yoshida Y, et al. Subcutaneous formulation of to- cilizumab for treatment of rheumatoid arthritis [J]. Ther Deliv, 2015 Mar,6 ( 3 ) :283-95.
3Rais R, Saeed M, Haider R, et al. Rheumatoid arthritis clinical fea- tures and management strategies at an urban tertiary facility in Paki- stan[J]. J Pak Med Assoc,2014,64(12) : 1435-1437.
4Duggins H. Treatment to target in rheumatoid arthritis [J]. Nurs Times ,2014,110 ( 12 ) : 19-21.
5Miossec P. Drug treatments for rheumatoid arthritis : looking backwards to move forwards [J]. BMJ,2015,13 ( 2 ) : 192-193.
6Miao CG,Zhou GL, Qin MS, et al. Treatment of rheumatoid arthritis with flavonoids of Echinps latifolius Tausch in rat model [J].Zhe- jiang DaXue Xue Bao Yi Xue Ban,2015,44( 1 ) :43-48.
7Londhey VA. Intra-articular steroids in 'treat-to-target' therapy in early rheumatoid arthritis [J]. J Assoc Physicians India, 2014,62 (8) :669-71.
